Wednesday, April 22, 1 p.m ET / 10 a.m PT
Stat’s Matthew Herper will talk with Diana Brainard, senior vice president, HIV and Emerging Viral Infections from Gilead Sciences. They’ll dive into the steps being taken to develop antiviral treatments and break down the big questions around time frame, testing, and more.